A different type of cardiomyopathy: ventricular noncompaction (evaluation of 8 cases)

Funda Oztunç1, Kadir Babaoğlu, Levent Saltik

  • 1Section of Pediatric Cardiology, Department of Pediatrics, Istanbul University Cerrahpaşa Faculty of Medicine, Istanbul, Turkey.

Insights

Ventricular noncompaction, a heart muscle disorder, is often misdiagnosed as cardiomyopathy. Early consideration of this condition aids in accurate diagnosis and management of heart abnormalities.

Area of Science:

  • Cardiology
  • Developmental Biology
  • Pathology

Background:

  • Ventricular noncompaction is a rare congenital heart defect characterized by excessive myocardial trabeculations and deep recesses.
  • It is believed to result from an arrest in myocardial development during fetal life.
  • This condition can lead to heart failure, arrhythmias, and thromboembolic events.

Purpose of the Study:

  • To report the clinical characteristics and diagnostic challenges of ventricular noncompaction.
  • To highlight the importance of considering ventricular noncompaction in the differential diagnosis of cardiomyopathies.
  • To review the presentation of ventricular noncompaction in a cohort of patients.

Main Methods:

  • Retrospective review of eight patients diagnosed with ventricular noncompaction over one year.
  • Analysis of clinical data, echocardiographic findings, and associated cardiac anomalies.
  • Comparison with initial diagnoses, particularly cardiomyopathies.

Main Results:

  • Eight patients diagnosed with ventricular noncompaction.
  • Six patients had isolated left ventricular noncompaction, one had biventricular involvement, and one had isolated right ventricular noncompaction.
  • Seven patients were initially misdiagnosed with other cardiomyopathies, underscoring diagnostic challenges.

Conclusions:

  • Ventricular noncompaction should be included in the differential diagnosis of cardiomyopathies.
  • Accurate diagnosis is crucial for appropriate management and to prevent complications.
  • Further research is needed to understand the morphogenesis and long-term outcomes of this condition.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...